377 related articles for article (PubMed ID: 15635680)
1. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer.
McCulloch P; Niita ME; Kazi H; Gama-Rodrigues JJ
Br J Surg; 2005 Jan; 92(1):5-13. PubMed ID: 15635680
[TBL] [Abstract][Full Text] [Related]
2. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2003; (4):CD001964. PubMed ID: 14583942
[TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues JJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD001964. PubMed ID: 22258947
[TBL] [Abstract][Full Text] [Related]
4. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2004 Oct; (4):CD001964. PubMed ID: 15495024
[TBL] [Abstract][Full Text] [Related]
5. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
6. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
7. Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer.
Hartgrink HH; van de Velde CJ
J Surg Oncol; 2005 Jun; 90(3):153-65. PubMed ID: 15895448
[TBL] [Abstract][Full Text] [Related]
8. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
9. [Clinical values of extended lymph node dissection for gastric cancer:a meta-analysis for D1 versus D2 gastrectomy].
Wang XF; Sun YH; Liang DJ; Wang C; Fang Y; Liu TS; Qin XY
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):425-30. PubMed ID: 17851781
[TBL] [Abstract][Full Text] [Related]
10. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
11. [Lymph node excision in cancer of the stomach].
Msika S
J Chir (Paris); 1998 Oct; 135(4):155-61. PubMed ID: 9827394
[TBL] [Abstract][Full Text] [Related]
12. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
[TBL] [Abstract][Full Text] [Related]
13. Extended lymphadenectomy in gastric cancer: when, for whom and why.
Roukos DH
Ann R Coll Surg Engl; 1998 Jan; 80(1):16-24. PubMed ID: 9579122
[TBL] [Abstract][Full Text] [Related]
14. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
[TBL] [Abstract][Full Text] [Related]
15. Optimal surgery for advanced gastric cancer.
Songun I; van de Velde CJ
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1849-58. PubMed ID: 19954295
[TBL] [Abstract][Full Text] [Related]
16. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
[TBL] [Abstract][Full Text] [Related]
17. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
18. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based medicine review of lymphadenectomy extent for gastric cancer.
Yang SH; Zhang YC; Yang KH; Li YP; He XD; Tian JH; Lv TH; Hui YH; Sharma N
Am J Surg; 2009 Feb; 197(2):246-51. PubMed ID: 18722583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]